Cargando…

Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease

BACKGROUND: Type 2 diabetes (DMT2) combined with ischemic heart disease (IHD) promotes the occurrence and development of coronary atherosclerosis. We aimed to provide a theoretical basis for improving patient prognosis through analyzing expression of plasma brain natriuretic peptide (BNP), endotheli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Chunfang, Ye, Meixin, Li, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514296/ https://www.ncbi.nlm.nih.gov/pubmed/26190179 http://dx.doi.org/10.12659/MSM.893375

Ejemplares similares

Plasma endothelin-1 and natriuretic peptide levels and antioxidant capacity of heart transplanted patients
por: Olejarova, I, et al.
Publicado: (2000)

Elevated plasma levels of endothelin are associated with the severity of sepsis and presence of shock in contrast to the levels of atrial natriuretic peptide
por: Beishuizen, A., et al.
Publicado: (1992)

Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria
por: Dietmann, Anelia, et al.
Publicado: (2008)

Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis
por: Barbe, Adrian Mykhailovych, et al.
Publicado: (2020)

Variations of atrial natriuretic peptide, cortisol and endothelin during different body positions
por: Heringlake, M, et al.
Publicado: (1997)

Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II
por: Vitlianova, Katerina, et al.
Publicado: (2015)

Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy
por: Salah, Mohab M., et al.
Publicado: (2019)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
por: Laroui, Asma, et al.
Publicado: (2022)

Serum Matrix Metalloproteinase‐9 and Cognitive Impairment After Acute Ischemic Stroke
por: Zhong, Chongke, et al.
Publicado: (2018)

High Plasma Levels of the B-type Natriuretic Peptide in Patients Without Heart Failure: Is There Clinical Significance?
por: Yu, Long Hao, et al.
Publicado: (2010)

Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes
por: Kostov, Krasimir, et al.
Publicado: (2016)

zDHHC9 and the Control of Natriuretic Peptide Secretion by the Heart
por: Fuller, William
Publicado: (2023)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Effect of statin therapy on plasma C-type Natriuretic Peptides and Endothelin-1 in males with and without symptomatic coronary artery disease
por: Prickett, Timothy C. R., et al.
Publicado: (2020)

Endothelin-1 induces extracellular matrix degradation via matrix metalloproteinases induction in human osteosarcoma cells
por: Felx, M, et al.
Publicado: (2004)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein
por: Alqahtani, Mashael F., et al.
Publicado: (2016)

Plasma brain natriuretic peptide concentrations in patients with valvular heart disease
por: Sharma, Vishal, et al.
Publicado: (2016)

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Endothelin-1 down-regulates matrix metalloproteinase 14 and 15 expression in human first trimester trophoblasts via endothelin receptor type B
por: Majali-Martinez, Alejandro, et al.
Publicado: (2017)

The involvement of osteopontin and matrix metalloproteinase- 9 in the migration of endometrial epithelial cells in patients with endometriosis
por: Yang, Mei, et al.
Publicado: (2015)

Plasma levels of pro-atrial natriuretic peptide, pro-adrenomedullin, and pro-endothelin-1 correlate with the severity of organ dysfunction in critically ill patients
por: Bloos, F, et al.
Publicado: (2006)

Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis
por: WANG, JIFENG, et al.
Publicado: (2016)

Plasma matrix metalloproteinases in neonates having surgery for congenital heart disease
por: Joffe, Ari R., et al.
Publicado: (2009)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke
por: Chang, Jason J., et al.
Publicado: (2016)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy
por: Kłysik, Anna B., et al.
Publicado: (2010)

Prognostic value of pro-atrial natriuretic peptide, pro-adrenomedullin, and pro-endothelin-1 in critically ill patients
por: Bloos, F, et al.
Publicado: (2006)

Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer
por: Wu, Qiu-Wan, et al.
Publicado: (2014)

Significance of Circulating and Crevicular Matrix Metalloproteinase-9 in Rheumatoid Arthritis-Chronic Periodontitis Association
por: Silosi, Isabela, et al.
Publicado: (2015)

Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases
por: Nakagawa, Hitoshi, et al.
Publicado: (2022)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_s3noiroeb8s6qceauk6k8o131s